Similar to testing a car, a team of researchers at UBC Okanagan has been test-driving a number of mechanical heart valves (MHV)—and the one designed in their own lab appears to outperform the others.

Although many patients requiring long term anti-thrombotic therapy now can be treated with direct oral anticoagulants (DOACs), vitamin K antagonists, such as warfarin, remain the only treatment option ...